VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edderd who wrote (19493)	3/11/1999 7:29:00 AM
From: BigKNY3	Read Replies (1) of 23519

Edderd: You may find these links of interest: FDA on the early stages of drug development: fda.gov The 1999 AUA Meeting Abstracts have been published including the first double-blind clinical study of sildenafil in women: Message 8255960 The abstract book has several MUSE studies.... including a positive study of MUSE in patients who were unresponsive or could not tolerate Viagra (#813). "57% of these patients achieved an erection sufficient for sexual intercourse..... Most common side effects were penile pain (13%) and urethral burning (5%)." These ED studies and many more will be presented in Dallas on May 1-6, 1999. BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next